We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMTD
26
DELISTED
TD Ameritrade Holding Corp
AMTD
| $58.7M | 1.18% |
1,842,369
-60,670
| -3% | -$2.13M |
|
27
Becton Dickinson
BDX
$51.2B
| $57.5M | 1.16% |
444,576
+96,082
| +28% | +$13.4M |
|
28
Home Depot
HD
$328B
| $57.3M | 1.16% |
496,030
-68,029
| -12% | -$7.87M |
|
|
CONE
29
DELISTED
CyrusOne Inc Common Stock
CONE
| $56.8M | 1.15% |
1,740,451
-71,992
| -4% | -$2.29M |
|
|
30
Gilead Sciences
GILD
$185B
| $55.2M | 1.11% |
562,458
+245,862
| +78% | +$27.3M |
|
31
Acadia Healthcare
ACHC
$2.81B
| $55M | 1.11% |
830,051
+27,405
| +3% | +$2.11M |
|
32
Affiliated Managers Group
AMG
$9.58B
| $53.5M | 1.08% |
313,157
-107,916
| -26% | -$21.2M |
|
|
33
Manhattan Associates
MANH
$13B
| $52.9M | 1.07% |
849,250
+539,317
| +174% | +$33.6M |
|
34
Union Pacific
UNP
$183B
| $51.9M | 1.05% |
587,014
-236,293
| -29% | -$21.6M |
|
35
Ulta Beauty
ULTA
$23.2B
| $51.9M | 1.05% |
317,450
+7,967
| +3% | +$1.31M |
|
36
Ameriprise Financial
AMP
$49.1B
| $48.4M | 0.98% |
443,160
-158,545
| -26% | -$18.7M |
|
|
TWX
37
DELISTED
Time Warner Inc
TWX
| $45.2M | 0.91% |
656,813
-388,310
| -37% | -$30.5M |
|
38
Brookfield
BN
$92.5B
| $45M | 0.91% |
4,076,377
-1,601,747
| -28% | -$18.7M |
|
39
Elevance Health
ELV
$86.6B
| $43M | 0.87% |
307,454
-114,988
| -27% | -$17.3M |
|
40
Icon
ICLR
$13.1B
| $41.9M | 0.85% |
590,823
-145,361
| -20% | -$10.9M |
|
41
Salesforce
CRM
$207B
| $41.9M | 0.85% |
603,804
+30,129
| +5% | +$2.14M |
|
42
Edwards Lifesciences
EW
$51.8B
| $41.2M | 0.83% |
1,739,892
+397,482
| +30% | +$9.59M |
|
43
Ecolab
ECL
$80.1B
| $39.1M | 0.79% |
356,652
+20,035
| +6% | +$2.24M |
|
44
Whirlpool
WHR
$2.59B
| $38M | 0.77% |
258,037
-59,521
| -19% | -$10.1M |
|
45
Idexx Laboratories
IDXX
$42.9B
| $36.6M | 0.74% |
492,915
+12,137
| +3% | +$869K |
|
|
MON
46
DELISTED
Monsanto Co
MON
| $36.4M | 0.73% |
426,153
-203,716
| -32% | -$20.1M |
|
47
Enterprise Products Partners
EPD
$84.3B
| $34.4M | 0.69% |
1,382,690
-51,799
| -4% | -$1.44M |
|
|
MHFI
48
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $33.8M | 0.68% |
390,847
+16,743
| +4% | +$1.65M |
|
49
AbbVie
ABBV
$456B
| $33.7M | 0.68% |
619,096
-262,307
| -30% | -$17.1M |
|
|
AGN
50
DELISTED
Allergan plc
AGN
| $33M | 0.67% |
121,532
+2,824
| +2% | +$867K |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.